QPCT and Alzheimer disease: It is suggested that pyroglutamylated Aβ plays a major role in AD pathogenesis, since, while there are similar amounts of non-modified Aβ in aged controls, pyroglutamylated Aβ is more abundant in AD and glutaminyl-cyclase activity is increased.